AGENT FOR PREVENTING OR TREATING DEMYELINATING DISEASE

摘要

The purpose of the present invention is to provide a drug that can promote the growth of oligodendrocyte precursor cells, and effectively prevent or treat demyelinating disease. FGF21 acts to promote the growth of oligodendrocyte precursor cells, and administering FGF21, DNA that encodes for FGF21, an FGF21 production-promoting substance, and/or FGF21-producing cells is effective in preventing or treating demyelinating disease.